Catalyst Wire Dossier Catalyst Wire Dossier

Imprida

valsartan; amlodipine · Novartis Europharm Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imprida, covering 2017-05-11 to 2017-05-11. Get the full timeline:

Most recent: EMA Withdrawn: Imprida (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Ltd

See pricing